RLMD – relmada therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Relmada Therapeutics (RLMD) was given a new $10.00 price target by Mizuho.
Why Relmada Therapeutics (RLMD) Is Up 38.8% After $160M Raise And Positive NDV-01 Phase 2 Data [Yahoo! Finance]
Relmada Therapeutics to Report Fourth Quarter 2025 Financial Results on Thursday, March 19, 2026
A Look At Relmada Therapeutics (RLMD) Valuation After NDV-01 Phase 2 Update And US$160 Million Private Placement [Yahoo! Finance]
50% and 61% Gains in a Single Day: Why XENE and RLMD Soared Today [Yahoo! Finance]
Form 8-K RELMADA THERAPEUTICS, For: Mar 09
Form SCHEDULE 13G/A RELMADA THERAPEUTICS, Filed by: Squadron Capital Management LLC
Form SCHEDULE 13G RELMADA THERAPEUTICS, Filed by: Spruce Street Capital LP
Form SCHEDULE 13G RELMADA THERAPEUTICS, Filed by: Adage Capital Management, L.P.
Form SCHEDULE 13G RELMADA THERAPEUTICS, Filed by: JANUS HENDERSON GROUP PLC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.